Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
OPERATING ACTIVITIES    
Net loss $ (82,295,266) $ (42,753,412)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 199,690 147,156
Impairment of intangible assets 3,900,000  
Provision for credit losses 3,911,714 (6,500)
Gain on sale of ENTADFI® assets (4,723,623)  
Noncash change in right-of-use assets 556,475 411,002
Noncash interest expense, net of interest paid 1,832,092 1,415,978
Share-based compensation 13,233,699 6,916,345
Deferred income taxes (213,172) 19,017
Change in fair value of derivative liabilities (2,319,000) 557,000
Other 195,877 69,633
Changes in assets and liabilities:    
Increase in accounts receivable (4,729,697) (930,021)
Decrease (increase) in inventories 845,688 (2,216,377)
Decrease (increase) in prepaid expenses and other assets 5,780,913 (1,737,701)
(Decrease) increase in accounts payable (3,884,800) 3,526,541
(Decrease) increase in accrued expenses and other current liabilities (10,358,135) 8,258,099
Decrease in operating lease liabilities (453,809) (303,266)
Net cash used in operating activities (78,521,354) (26,626,506)
INVESTING ACTIVITIES    
Cash proceeds from sale of ENTADFI® assets 6,000,000  
Cash proceeds from sale of PREBOOST® business   5,000,000
Capital expenditures (452,826) (584,245)
Net cash provided by investing activities 5,547,174 4,415,755
FINANCING ACTIVITIES    
Proceeds from stock option exercises 336,610 410,919
Proceeds from sale of shares 3,400,000  
Payment of deferred equity financing issuance costs (263,757)  
Proceeds from premium finance agreement 1,425,174  
Installment payments on premium finance agreement (897,422)  
Cash paid for debt portion of finance lease   (9,093)
Net cash provided by financing activities 8,996,641 401,826
Net decrease in cash (63,977,539) (21,808,925)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 80,190,675 122,359,535
CASH AND CASH EQUIVALENTS AT END OF PERIOD 16,213,136 100,550,610
Supplemental disclosure of cash flow information:    
Cash paid for interest 387,748 2,140,499
Schedule of non-cash investing and financing activities:    
Shares issued in connection with common stock purchase agreement 1,008,000  
Right-of-use asset recorded in exchange for lease liabilities 264,896 $ 4,411,474
Amortization of deferred costs related to common stock purchase agreement 104,849  
Aspire Capital Purchase Agreement, 2020 [Member]    
FINANCING ACTIVITIES    
Proceeds from sale of shares 3,426,991  
Stock Purchase Agreement With Frost Gamma Investment Trust (FGI) [Member]    
FINANCING ACTIVITIES    
Proceeds from sale of shares $ 4,969,045